KindlyMD (NAKA) Competitors $2.78 -1.16 (-29.44%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock NAKA vs. RDNT, OPCH, SHC, BTSG, WGS, CON, SGRY, PRVA, HTFL, and VCYTShould you be buying KindlyMD stock or one of its competitors? The main competitors of KindlyMD include RadNet (RDNT), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), Heartflow (HTFL), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. KindlyMD vs. Its Competitors RadNet Option Care Health Sotera Health BrightSpring Health Services GeneDx Concentra Group Holdings Parent Surgery Partners Privia Health Group Heartflow Veracyte KindlyMD (NASDAQ:NAKA) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends. Do analysts recommend NAKA or RDNT? KindlyMD presently has a consensus target price of $8.00, suggesting a potential upside of 187.77%. RadNet has a consensus target price of $76.80, suggesting a potential upside of 3.77%. Given KindlyMD's higher possible upside, equities analysts clearly believe KindlyMD is more favorable than RadNet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KindlyMD 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00RadNet 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 3 Strong Buy rating(s) 3.25 Which has stronger valuation & earnings, NAKA or RDNT? RadNet has higher revenue and earnings than KindlyMD. RadNet is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKindlyMD$2.72M384.42-$3.62M-$0.86-3.23RadNet$1.83B3.11$2.79M-$0.20-370.05 Does the media favor NAKA or RDNT? In the previous week, RadNet had 2 more articles in the media than KindlyMD. MarketBeat recorded 14 mentions for RadNet and 12 mentions for KindlyMD. RadNet's average media sentiment score of 1.13 beat KindlyMD's score of 0.41 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KindlyMD 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral RadNet 8 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, NAKA or RDNT? KindlyMD has a beta of 33.96, indicating that its stock price is 3,296% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500. Do institutionals & insiders hold more shares of NAKA or RDNT? 77.9% of RadNet shares are held by institutional investors. 40.8% of KindlyMD shares are held by insiders. Comparatively, 5.6% of RadNet shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is NAKA or RDNT more profitable? RadNet has a net margin of -0.78% compared to KindlyMD's net margin of -244.00%. RadNet's return on equity of 2.41% beat KindlyMD's return on equity.Company Net Margins Return on Equity Return on Assets KindlyMD-244.00% -131.09% -106.04% RadNet -0.78%2.41%0.82% SummaryRadNet beats KindlyMD on 12 of the 17 factors compared between the two stocks. Get KindlyMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NAKA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAKA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAKA vs. The Competition Export to ExcelMetricKindlyMDMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.48B$7.68B$5.86B$10.15BDividend YieldN/A2.76%5.68%4.59%P/E Ratio-3.2374.0174.5225.93Price / Sales384.4242.71536.78122.58Price / CashN/A24.1437.5660.44Price / Book6.477.3512.166.29Net Income-$3.62M$238.91M$3.28B$270.77M7 Day Performance-31.86%2.63%0.98%3.36%1 Month Performance-74.93%3.08%7.20%6.41%1 Year PerformanceN/A20.54%63.06%28.26% KindlyMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAKAKindlyMD2.438 of 5 stars$2.78-29.4%$8.00+187.8%N/A$1.48B$2.72M-3.23N/ANews CoverageOptions VolumeGap DownHigh Trading VolumeRDNTRadNet3.427 of 5 stars$70.31-2.0%$71.60+1.8%+18.3%$5.52B$1.83B-351.5311,021Insider TradeOPCHOption Care Health4.8747 of 5 stars$28.44-0.8%$35.75+25.7%-9.4%$4.65B$5.00B22.758,088Positive NewsSHCSotera Health2.1627 of 5 stars$16.16-1.3%$16.00-1.0%-0.4%$4.65B$1.10B202.033,000Insider TradeBTSGBrightSpring Health Services2.8159 of 5 stars$23.88+0.8%$25.67+7.5%+107.0%$4.20B$11.27B77.0335,000News CoverageAnalyst ForecastWGSGeneDx2.5773 of 5 stars$128.18-1.0%$101.63-20.7%+257.0%$3.72B$305.45M2,563.601,200Positive NewsAnalyst ForecastCONConcentra Group Holdings Parent3.0353 of 5 stars$23.77-0.1%$27.50+15.7%-3.7%$3.05B$1.90B19.9711,250Positive NewsSGRYSurgery Partners3.1614 of 5 stars$22.58-0.5%$33.00+46.1%-27.4%$2.91B$3.11B-15.7915,000Positive NewsPRVAPrivia Health Group4.5292 of 5 stars$23.19+0.7%$28.08+21.1%+25.5%$2.83B$1.74B210.841,140Gap UpHTFLHeartflowN/A$31.16-1.1%$35.80+14.9%N/A$2.56BN/A0.00699Quiet Period ExpirationGap UpVCYTVeracyte3.8619 of 5 stars$30.11-0.8%$40.90+35.8%+5.1%$2.39B$445.76M91.25790Positive News Related Companies and Tools Related Companies RadNet Alternatives Option Care Health Alternatives Sotera Health Alternatives BrightSpring Health Services Alternatives GeneDx Alternatives Concentra Group Holdings Parent Alternatives Surgery Partners Alternatives Privia Health Group Alternatives Heartflow Alternatives Veracyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAKA) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KindlyMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KindlyMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAKA Stock Alerts